Actimed Therapeutics Enrolls First Patients in Phase 2a PROACT Study Programme to Assess S-pindolol benzoate in Obese Patients During and Post-GLP-1 Agonist Therapy
Two-part clinical study programme to evaluate change in lean and fat mass in patients receiving two different doses of S-pindolol…
